Stay updated on TAPUR Study: Targeted Drug Clinical Trial

Sign up to get notified when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TAPUR Study: Targeted Drug Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a new publication entry for Veljovich et al. on Palbociclib in ovarian cancer with CDKN2A alterations to the Publications section. The page revision was updated from v3.6.3 to v3.6.4.
    Difference
    0.0%
    Check dated 2026-07-22T15:55:30.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.3, reflecting an updated revision of the page's metadata.
    Difference
    0.0%
    Check dated 2026-07-01T02:47:13.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The revision tag updated from v3.5.4 to v3.5.5, signaling a minor backend or documentation update to the page without altering displayed study details.
    Difference
    0.0%
    Check dated 2026-06-09T16:11:43.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Puerto Rico site contacts were added (Natalia Ortiz and Maria Cruz Correa). The total number of locations was updated to 181, and the site list expanded accordingly.
    Difference
    0.8%
    Check dated 2026-06-02T13:49:18.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Updated TAPUR study page contact details: Alex Lizzul and Davendra Sohal, MD were added as contacts, with Russell Fernandez and Trisha Wise-Draper, MD removed. This change reflects updated governance and communication points for the study.
    Difference
    0.1%
    Check dated 2026-05-18T13:27:33.000Z thumbnail image
  9. Check
    86 days ago
    Change Detected
    Summary
    A new publication entry has been added to the Publications section for the TAPUR study: 'Nivolumab Plus Ipilimumab in Patients With Solid Tumors With High Tumor Mutation Burden: Results From the Targeted Agent and Profiling Utilization Registry Study' (JCO Precis Oncol, 2026). This expands the registry's linked literature and reflects ongoing dissemination of TAPUR results.
    Difference
    0.0%
    Check dated 2026-05-11T11:48:24.000Z thumbnail image

Stay in the know with updates to TAPUR Study: Targeted Drug Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TAPUR Study: Targeted Drug Clinical Trial page.